Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator

Three patients affected by Behçet’s disease (BD) with severe uveitis and neurological involvement in stable clinical remission and who rapidly relapsed after switching from reference infliximab (re-IFX) to biosimilar infliximab (bio-IFX) are reported. In order to observe the rules of local health au...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur J Rheumatol
Autores principales: Cantini, Fabrizio, Niccoli, Laura, Nannini, Carlotta, Cassarà, Emanuele, Kaloudi, Olga
Formato: Artigo
Lenguaje:Inglês
Publicado: Medical Research and Education Association 2017
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5741345/
https://ncbi.nlm.nih.gov/pubmed/29308287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2017.16112
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares